GGrantIndex
Sort

30,917 grants matching tumor microenvironment

UCLA SPORE in Brain Cancer

$2,046,459
Linda M Liau · University Of California Los Angeles · P50 · FY2022 · CA

MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors

$2,046,454
Forest M White · Massachusetts Institute Of Technology · U54 · FY2018 · CA

UCLA SPORE in Brain Cancer

$2,046,404
Linda M Liau · University Of California Los Angeles · P50 · FY2023 · CA

Centers for Cancer Systems Therapeutics (CaST)

$2,041,589
Andrea Califano · Columbia University Health Sciences · U54 · FY2020 · CA

Preclinical GEM and GDA Models of Primary and Metastatic Melanoma

$2,041,466
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$2,037,244
Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA

Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases

$2,033,275
Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2025 · AR

Identifying Metabolic Vulnerabilities in Lung Cancer

$2,032,950
Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

$2,032,638
Peter Karl Sorger · Harvard Medical School · U54 · FY2021 · CA

Molecular Profiling of Clinical Specimens

$2,032,400
Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Mayo Clinic Multiple Myeloma SPORE

$2,031,615
Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2022 · CA

SPORE in Breast Cancer

$2,031,380
Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2022 · CA

Identifying Metabolic Vulnerabilities in Lung Cancer

$2,029,016
Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2022 · CA

Head and Neck Cancer SPORE at the University of Wisconsin

$2,028,647
Paul M Harari · University Of Wisconsin-Madison · P50 · FY2022 · CA

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$2,028,388
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Plasma Cells in Health and Disease

$2,027,642
Ignacio E. Sanz · Emory University · P01 · FY2017 · AI

Plasma Cells in Health and Disease

$2,027,087
Ignacio E. Sanz · Emory University · P01 · FY2018 · AI

Plasma Cells in Health and Disease

$2,026,518
Ignacio E. Sanz · Emory University · P01 · FY2019 · AI

Plasma Cells in Health and Disease

$2,025,932
Ignacio E. Sanz · Emory University · P01 · FY2020 · AI

MOTILITY AND INVASION

$2,023,001
John S Condeelis · Albert Einstein College Of Medicine · P01 · FY2011 · CA

Pancreatic Cancer Development: Genetic and Immune Regulation

$2,023,000
Seung K Kim · Stanford University · P01 · FY2025 · CA

PLT+ Characterization and IND-Enabling Studies

$2,022,100
Dean Alan Falb · Stellular Bio, Inc. · R44 · FY2020 · HL

Interstitial fluid flow in Alzheimer's Disease Progression

$2,021,966
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · RF1 · FY2021 · AG

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

$2,021,847
Quynh-Thu X Le · Stanford University · P01 · FY2023 · CA

Role of O-glycosylation in Animal Development

$2,021,527
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE